shutterstock-71191654-web
Morphart Creation / Shutterstock.com
3 March 2015Americas

AstraZeneca boosts respiratory unit with Actavis deal

AstraZeneca has closed a deal that will see it acquire the rights to Actavis’s branded respiratory drugs business in the US and Canada, it was announced today (March 3).

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk


More on this story

Americas
5 May 2016   AstraZeneca has completed its acquisition of pharmaceutical company Takeda’s respiratory business.

More on this story

Americas
5 May 2016   AstraZeneca has completed its acquisition of pharmaceutical company Takeda’s respiratory business.

More on this story

Americas
5 May 2016   AstraZeneca has completed its acquisition of pharmaceutical company Takeda’s respiratory business.